Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
China
· Delayed Price · Currency is CNY 56.80
-1.75 (-2.99%)
At close: Apr 23, 2025, 2:57 PM CST
SHE:301033 Market Cap
SHE:301033 has a market cap or net worth of 4.00 billion as of April 24, 2025. Its market cap has increased by 87.12% in one year.
Market Cap
4.00B
Enterprise Value
3.82B
Revenue
276.03M
Ranking
n/a
PE Ratio
57.74
Stock Price
56.80
Market Cap Chart
Since July 26, 2021, SHE:301033's market cap has decreased from 4.69B to 4.00B, a decrease of -14.83%. That is a compound annual growth rate of -4.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 4.00B | 43.64% |
| Dec 31, 2024 | 2.78B | -3.27% |
| Dec 29, 2023 | 2.88B | 18.06% |
| Dec 30, 2022 | 2.44B | -39.66% |
| Dec 31, 2021 | 4.04B | -13.95% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 312.65B |
| Shenzhen Mindray Bio-Medical Electronics | 261.25B |
| WuXi AppTec | 153.68B |
| Zhangzhou Pientzehuang Pharmaceutical., | 124.28B |
| Aier Eye Hospital Group | 119.65B |
| Shanghai United Imaging Healthcare | 105.56B |
| Sichuan Biokin Pharmaceutical | 104.93B |
| Yunnan Baiyao Group Co.,Ltd | 102.51B |